Rapt Therapeutics initiated with a Buy at Clear Street
Clear Street initiated coverage of Rapt Therapeutics (RAPT) with a Buy rating and $3 price target
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 hours ago
- Yahoo
Citi sees Gilead clinical holds as only ‘minor setback'
Citi analyst Geoff Meacham keeps a Buy rating on Gilead (GILD) with a $125 price target after the company announced a clinical hold on its Phase 2 WONDERS trials evaluating the combination of GS-1720 and GS-4182 for once-weekly oral HIV treatment. The hold was initiated due to safety concerns, specifically decreases in CD4+ T-cell and absolute lymphocyte counts observed in a subset of participants receiving the combination therapy, the analyst tells investors in a research note. Citi says the setback impacts the targeted commercial launch of the GS-1720/GS-4182 regimen, previously anticipated in 2029 or 2030. The hold does not affect Gilead's other ongoing HIV programs, including lenacapavir development for both treatment and prevention including the monthly oral combinations, as no similar lymphocyte or CD4 effects have been observed in these studies, Citi points out. As such, the firm sees the holds as a 'minor setback' and continues to believe that lenacapavir in pre-exposure prophylaxis and expansion of several differentiated lenacapavir combos should offset potential Biktarvy 2028 Inflation Reduction Act negotiations. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on GILD: Disclaimer & DisclosureReport an Issue FDA placed clinical hold on Gilead HIV treatment trials of GS-1720 Gilead down 2% to $111.14 after FDA placed hold on some HIV trials Gilead Sciences: Strong Market Position and Growth Potential Drive Buy Rating Gilead Sciences' Oncology Advancements: Trodelvy's Potential to Boost Stock Value Gilead Sciences: Promising Pipeline and Strategic Advancements Justify Buy Rating Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
8 hours ago
- Yahoo
Mixed options sentiment in CrowdStrike Holdings with shares up 0.12%
Mixed options sentiment in CrowdStrike Holdings (CRWD), with shares up 55c, or 0.12%, near $464.94. Options volume relatively light with 5050 contracts traded and calls leading puts for a put/call ratio of 0.48, compared to a typical level near 0.76. Implied volatility (IV30) dropped 0.2 near 35.4,in the bottom quartile of the past year, suggesting an expected daily move of $10.37. Put-call skew steepened, indicating increased demand for downside protection, following a downgrade to In Line at Evercore ISI. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on CRWD: Disclaimer & DisclosureReport an Issue Trump Trade: U.S., China representatives to meet about trade Cardinal Health, Dollar General, Snowflake, Constellation, and CrowdStrike: Trending by Analysts Trump signs Executive Order intended to 'strengthen the nation's cybersecurity' U.S. Layoffs Surge despite Strong Jobs Data as Major Corporations Make Cuts U.S. payrolls rise 139,000, Broadcom reports Q2 beat: Morning Buzz Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
8 hours ago
- Yahoo
Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter VACCINE ADVISORY COMMITTEE: In an opinion article published by The Wall Street Journal, Robert F. Kennedy Jr. stated, 'Vaccines have become a divisive issue in American politics, but there is one thing all parties can agree on: The U.S. faces a crisis of public trust. Whether toward health agencies, pharmaceutical companies or vaccines themselves, public confidence is waning… That is why, under my direction, the U.S. Department of Health and Human Services is putting the restoration of public trust above any pro- or antivaccine agenda… Today, we are taking a bold step in restoring public trust by totally reconstituting the Advisory Committee for Immunization Practices. We are retiring the 17 current members of the committee, some of whom were last-minute appointees of the Biden administration. Without removing the current members, the current Trump administration would not have been able to appoint a majority of new members until 2028… A clean sweep is needed to re-establish public confidence in vaccine science.' DRUG PRICES: Pfizer (PFE) and other drugmakers met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Pfizer CEO Albert Bourla said on Monday at the Goldman Sachs Healthcare Conference. Boula said the meetings 'were cordial,' but they were not 'digging into the substance yet,' adding that 'it is just trying to understand high-level ideas and no commitments. So what could be the outcomes of something like that? It could be from nothing to very big.' TRUMP WISHES MUSK WELL: While speaking to reporters from the White House, President Trump said that he wishes Tesla (TSLA) CEO Elon Musk 'well' and downplayed a dispute with the former DOGE advisor. LIVE MUSIC VENUES: Live Nation (LYV) CEO Michael Rapino told Fox News Digital that after President Donald Trump's March executive order targeting ticket scalpers and strengthening protection for artists and their fans that the company is investing $1B to build new and revitalized live music venues in an effort to bring more big shows to smaller cities. 'Our mission is simple: help artists deliver more unforgettable live experiences – and in doing so, create jobs, revive cities, and lift up communities we touch,' Live Nation's Rapino is quoted as having told Fox News. BENEFICIARY OF ADDITIONAL TARIFFS: Raymond James says Market Perform-rated Whirlpool (WHR) is a possible incremental beneficiary of additional tariffs under Section 232 in the near future, though the ultimate policy remains unclear. Just last week, Trump increased section 232 rates on both steel and aluminum to 50% from 25% prior. Thus, the most recent developments seem to point to a redux of the net negative outcome of the first Trump administration, the firm notes. Trump's executive order last week increasing the 232 rates also amended the list of 'derivative products' included in the policy. The final lists published in the Federal Register continue to only include gas ranges, though a few aluminum parts used in appliances were also added. However, Raymond James points out that a list sent out by U.S. Customs on June 4 did include many major appliance categories. Subsequently, this morning, U.S. Customs subsequently sent out a new list, which matched today's Federal Register. It is unclear to the firm whether the June 4th list was simply a clerical error or a sign of things to come. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on JNJ: Disclaimer & DisclosureReport an Issue Deutsche Bank Sounds Alarm on Intuitive Surgical Stock (ISRG) with a Rare 'Sell' Rating RFK Jr. reconstituting vaccine advisory committee, retiring 17 current members RFK Jr. removes members of vaccine-advising CDC panel, CNBC reports Vaccine opponent hired by RFK Jr. searches CDC record for autism link, WSJ says Cautious Hold Rating for Johnson & Johnson Amid Promising Oncology Advances and Competitive Challenges Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
